iiinova — where your digital self keeps evolving

Anna Obenauf @obenaufa.bsky.social · 21/09/2026

We are so excited to have @dorie00.bsky.social Doris Kaltenecker join the @impvienna.bsky.social soon. Doris is using cutting edge technologies to study cancer cachexia. I can highly recommend joining a junior lab and can't wait to have her around!

1155

Anna Obenauf @obenaufa.bsky.social · 27/04/2026

Three more days to apply for the *Swiss Bridge Award*! This time focusing on Tumor Heterogeneity. It truly is a wonderful grant opportunity with maximum flexibility for an innovative project. www.swissbridge.ch/call-for-app...

swissbridge.ch

Call for application - SwissBridge

082

Reposted by Anna Obenauf

IMP @impvienna.bsky.social · 27/03/2026

🎉 Congratulations to our Anna Obenauf, IMP Senior Group Leader, who has been elected as a Corresponding Member of the Austrian Academy of Sciences, for her outstanding contributions to cancer research: www.imp.ac.at/news/article/anna-obe…

2172

Reposted by Anna Obenauf

Fusion Conferences @fusionconf.bsky.social · 02/02/2026

📢Want to speak at the #CancerImmuno conference? Good news! The chairs have released additional short talk slots and extended the submission deadline to 26 February 2026! Submit your abstract for a chance to present your work alongside leading researchers in the field. 👉 Register now: bit.ly/3NRB7Iu

243

Reposted by Anna Obenauf

Fusion Conferences @fusionconf.bsky.social · 12/01/2026

#CancerImmuno Early Bird & Talk Submission Deadline closing this week!!! 🚨 Click here to register now: bit.ly/4sGvk8E #FusionImmunology #FusionCancerResearch

251

Anna Obenauf @obenaufa.bsky.social · 18/12/2025

Thrilled and honored to be awarded the 2025 EJI Ita Askonas Prize by @efis-immunology.bsky.social ! 🎉 So grateful to the committee and especially to my incredible team and collaborators — this wouldn’t be possible without you! www.efis.org/news/2025-ej...

efis.org

2025 EJI Ita Askonas Prize awarded by EFIS

1271

Reposted by Anna Obenauf

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 11/12/2025

Beautiful talk by @obenaufa.bsky.social at #THPT25 — first walking us through the key conclusions of her latest Nature paper, then offering a glimpse into the next chapter of her work unravelling the mysteries of drug tolerant persistent cells. Looking forward to see where this story goes next!

0112

Anna Obenauf @obenaufa.bsky.social · 10/12/2025

Amazing talk by @johannajoyce.bsky.social at #THPT25 — an impressive tour de force, beautifully contextualizing two decades of work. 😍

0172

Anna Obenauf @obenaufa.bsky.social · 09/12/2025

Really exciting lineup of speakers in a beautiful venue. I really look forward to it! #cancerimmunology

050

Anna Obenauf @obenaufa.bsky.social · 13/10/2025

Acidosis is not just a byproduct of an altere Metabolism - it drives cancer cells‘ stress resilience mechanisms. Big congratulations to our friends from the @johanneszuber.bsky.social lab as well as the team around @wilhelmpalm.bsky.social on this wonderful story now out in Science.

0156

Anna Obenauf @obenaufa.bsky.social · 13/10/2025

Excited to present at the @metastasisresearch.bsky.social webinar soon. Registration is free!

0195

Reposted by Anna Obenauf

Laoui Team @ VIB-VUB @laouimmunology.bsky.social · 07/10/2025

The Laoui Lab will be well represented at the Tumor Heterogeneity, Plasticity and Therapy (3rd edition) conference #THPT25! Join us to hear more about therapy resistence in #cancer from Anna Obenauf @obenaufa.bsky.social Submit your abstract by the 8th of October on vibbio.tech/THPT25

053

Reposted by Anna Obenauf

Max Perutz Labs Vienna @maxperutzlabs.ac.at · 25/09/2025

Paper alert! 📢 How do cells strike the perfect balance during meiosis? ⚖️ A new study from the Matos lab in @natureportfolio.nature.com uncovers how Holliday junctions and the synaptonemal complex safeguard crossovers ➡️ tinyurl.com/2k4mmpzu @univie.ac.at @meduniwien.ac.at

04510

Anna Obenauf @obenaufa.bsky.social · 12/09/2025

I feel deeply honored to receive the 2025 Dr. Josef Steiner Cancer Research Award for our work on decoding and rewiring the immune-evasive TME. It truly is a recognition of the entire team past and present as well as our collaborators and mentors.🙌 Thank you for your trust!

1412110

Anna Obenauf @obenaufa.bsky.social · 09/09/2025

🔥Trio Fatale: Neutrophils, NETs and Necrosis 👉 authors.elsevier.com/a/1lk-k3qNrU... We summarized for @cp-immunity.bsky.social "Neutrophils drive vascular occlusion, tumour necrosis and metastasis" published in @nature.com by @megeblad.bsky.social @adrover.bsky.social rdcu.be/eFdau Congrats!

0337

Anna Obenauf @obenaufa.bsky.social · 09/09/2025

Excited to be in Paris this week for a joint seminar at @institutcurie.bsky.social and @institutpasteur.bsky.social . Looking forward to connecting with colleagues—and to showing my 👧 the city!

070

Anna Obenauf @obenaufa.bsky.social · 28/08/2025

Anyone working in metastasis research – the BEUG Foundation has once again opened the call for their Metastasis Research Prize. This prize is a wonderful recognition of innovative contributions and supports excellence in metastasis research across Europe. www.beugstiftung-metastase.de/apply-now/

beugstiftung-metastase.de

Apply now – Beugstiftung

01311

Anna Obenauf @obenaufa.bsky.social · 28/08/2025

As an academic editor: THANK YOU to anyone who declines a review but suggests alternative reviewers. Those suggestions are often spot on — especially junior scientists with the right expertise who give outstanding, detailed reviews. So helpful!

0402

Anna Obenauf @obenaufa.bsky.social · 13/07/2025

Big congratulations to Karin on this well-deserved recognition! @nkinl.bsky.social

0131

Anna Obenauf @obenaufa.bsky.social · 02/07/2025

Big congratulations to all the newly elected @embo.org Members! A special shoutout to @impvienna.bsky.social #ClemensPlaschka for this well-deserved recognition. Your contributions to life sciences continue to inspire and I count myself lucky to work with you!

embo.org

Outstanding life scientists elected to the EMBO Membership – Press releases – EMBO

Sixty-nine new members join the community of leading life scientists in Europe and beyond

0162

Anna Obenauf @obenaufa.bsky.social · 20/05/2025

🇦🇹 Scientists in Austria: Don’t miss this chance to hear directly from @embo.org Director Fiona Watt about funding opportunities available. A great way to learn and connect with the community! @vbcscitraining.bsky.social @impvienna.bsky.social

096

Anna Obenauf @obenaufa.bsky.social · 04/05/2025

⭐ Faculty for the Future Fellows ⭐ Interesting opportunity for women scientists from the world’s developing and emerging economies schlumbergerfoundation.com/eligibility-...

schlumbergerfoundation.com

Eligibility Criteria - Schlumberger Foundation

046

Reposted by Anna Obenauf

Keystone Symposia @keystonesymposia.bsky.social · 20/03/2025

🎉 Huge congratulations to our incredible scholarship recipients at the Cancer Immunotherapy/Immune Cell Therapies joint meeting! We hope your time in Banff was as inspiring and productive as you are. 🌟https://keysym.us/scholarshipssms. #KSCancerImmune25 #KSCellTherapy25 @obenaufa.bsky.social

022

Anna Obenauf @obenaufa.bsky.social · 14/03/2025

So excited about @georgwinter.bsky.social being appointed as the new life science director of the Research Institute for Biomedical Artificial Intelligence, established with generous funding/support from @boehringerglobal.bsky.social and OeAW. A truly fantastic choice! Welcome to the VBC Georg!

191

Anna Obenauf @obenaufa.bsky.social · 16/02/2025

So proud of you @aelewaut.bsky.social and big thank you to the ADF and @abbvie.bsky.social. This 💶 will help ease the start in the US #postdoc #newadventures

0342

Reposted by Anna Obenauf

IMP @impvienna.bsky.social · 14/02/2025

🎉Congratulations to @aelewaut.bsky.social, recent PhD graduate from the @obenaufa.bsky.social’s lab, who won the Egon Macher Award for her research on how cancer evades the immune system! Read more: www.imp.ac.at/news/article... @viennabiocenter.bsky.social

1624

Anna Obenauf @obenaufa.bsky.social · 13/02/2025

Excited to be back at my home turf. Big thanks for inviting me to the 2025 DocDay at the MedUni Graz. It’s been a while since I attended the 1st Doc Day #blastfromthepast

0130

Anna Obenauf @obenaufa.bsky.social · 11/02/2025

Miriam Molina Arcas from the Downward lab is presenting their exciting work on how to engage the immune system in KRAS driven tumors @molinaarcas.bsky.social @juliandownward.bsky.social important concepts close to my ❤️

1112

Anna Obenauf @obenaufa.bsky.social · 11/02/2025

Starting now! EACR-Boehringer Ingelheim Conference on Drugging and Regulating the MAP Kinase Pathway @helloeacr.bsky.social @boehringerglobal.bsky.social Looking forward to two days of exciting science and engaging discussions!

1102

Reposted by Anna Obenauf

Adaptmet @adaptmet.bsky.social · 10/02/2025

🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch

2133

Reposted by Anna Obenauf

IMP @impvienna.bsky.social · 10/02/2025

At the IMP we’re dedicated to the fun of finding out. Few places in the world let you dive into curiosity-driven science like we do. 📽️Watch what the IMP is all about: youtu.be/mtl5Vod652Q @viennabiocenter.bsky.social

1234

Reposted by Anna Obenauf

Caetano Reis e Sousa @reisesousalab.bsky.social · 06/01/2025

Happy New Year! I am a newly-arrived refugee from the other platform. Looking forward to (re-)connecting with friends and colleagues in this community!

610820

Anna Obenauf @obenaufa.bsky.social · 06/01/2025

🌟Keystone Cancer Immunotherapy conference 2025 🌟 Speaker Highlight #2 at #KSCancerImmune25: Dr. Ton N. Schumacher @nkinl.bsky.social will discuss how T cells detect tumors in “Dissecting T Cell Recognition of Cancer.” Don’t miss his cutting-edge immunology insights!

1206

Anna Obenauf @obenaufa.bsky.social · 06/01/2025

🌟Keystone Cancer Immunotherapy conference 2025 🌟 #KSCancerImmune25 Speaker Highlight #1 Dr. Carl June, the father of CAR T-cell therapy and 2024 #BreakthroughPrize winner will share critical advances in cancer immunology in his talk “Cell Therapies: Current State of the Art”.

1251

Anna Obenauf @obenaufa.bsky.social · 02/01/2025

The new CRISPR-StAR tool by @ulielling.bsky.social and team provides elegant new opportunities for in vivo screens. Glad we @aelewaut.bsky.social could contribute a bit.

0195

Anna Obenauf @obenaufa.bsky.social · 02/01/2025

Congratulations on this body of work! What a great start into 2025 for the @mafdawson.bsky.social lab!

180

Reposted by Anna Obenauf

Chris Marine Lab @marinelab.bsky.social · 17/12/2024

Looking for an enthusiastic bioinformatician (long-term postdoctoral follow or staff scientist) interested in cancer/melanoma biology and therapy resistance. Data Science (single-cell, spatial multiomics integration), Machine learning, R, Pyhthon... jobso.id/ik9e

jobso.id

Bioinformatician Postdoctoral Level - VIB

Position summary The Chris Marine lab at the VIB Center for Cancer Biology (https://ccb.sites.vib.be/en) is actively seeking a skilled bioinformatician proficient in analyzing and integrating single-...

02318

Anna Obenauf @obenaufa.bsky.social · 14/12/2024

Thrilled to share that our paper www.nature.com/articles/s41... is featured in a fantastic Nature News & Views piece by thomastueting.bsky.social! 🎉 Grateful for the spotlight on our research and its impact on understanding cancer immunology. www.nature.com/articles/d41... 👀👉 rdcu.be/d3cRz

nature.com

A lipid made by tumour cells reprograms immune cells

Insights into how cancer cells become unresponsive to therapy.

015323

Anna Obenauf @obenaufa.bsky.social · 06/12/2024

The kids are absolutely loving Prof. Bombasti at our annual Holiday Party! 😍 It’s such a joy to see them return year after year and watch them grow. @impvienna.bsky.social @vbcscitraining.bsky.social @viennabiocenter.bsky.social #WorkLifeIntegration

0191

Reposted by Anna Obenauf

Elizabeth McKenna @elizsmckenna.bsky.social · 03/12/2024

The December issue of Cancer Discovery is now online! The cover features work by Christopher Vakoc and colleagues (@cshlnews.bsky.social) showing that MARK2/MARK3 kinases are catalytic codependencies of YAP/TAZ in human cancer. Find it here: aacrjournals.org/cancerdiscov...

092

Anna Obenauf @obenaufa.bsky.social · 03/12/2024

Another interesting approach to improve T cell mediated immunity by the Elledge lab!

0100

Anna Obenauf @obenaufa.bsky.social · 03/12/2024

Congratulations to the #ERCCog recipients! 🎉 To everyone who applied but didn’t make it this time - keep pushing forward. We need more funds to support the brilliant ideas out there! tinyurl.com/ercog2024ls

tinyurl.com

0120